Does Oscar Health Cover Mounjaro?
The verdict
Conditional on most plans
Oscar Health covers Mounjaro for type 2 diabetes with prior authorization on its commercial and ACA/individual plans. No Oscar plan covers Mounjaro for weight loss. For weight loss, the same active ingredient (tirzepatide) is available as Zepbound — a separate FDA approval with separate, commonly excluded coverage on ACA plans. Tier and specific cost-share are not publicly published at the drug level for Oscar's state-specific plans; verify via the Oscar drug lookup tool.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Oscar Health using your member ID.
Key facts
Oscar Health operates primarily in the ACA individual and small-group markets, where weight-loss GLP-1s are commonly excluded. Mounjaro is covered for type 2 diabetes only.
Oscar Health, drug lookup and formulary, 2025-2026
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes only. The weight-loss tirzepatide product is Zepbound — a separate FDA approval for chronic weight management and OSA.
FDA drug labeling, Mounjaro and Zepbound prescribing information
ACA individual market plans commonly exclude weight-loss GLP-1s (Zepbound, Wegovy) under essential health benefit rules, even when the same plan covers diabetes GLP-1s (Mounjaro, Ozempic).
KFF: ACA Marketplace Plan Coverage of Weight Loss Drugs, 2025
Medicare vs. commercial coverage
Whether Oscar Health covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Oscar Health has limited Medicare Part D presence. Where applicable, Mounjaro is covered for type 2 diabetes only under standard Part D rules with prior authorization. The 2026 Part D OOP cap is $2,100. Mounjaro is NOT in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. Weight-loss coverage is not available under Medicare for Mounjaro. Verify on your specific Oscar Medicare plan if enrolled.
Commercial / Employer
Group & marketplace plans
Oscar commercial/small-group plans cover Mounjaro for type 2 diabetes with prior authorization and step therapy. Specific tier and copay are not publicly published at the drug level for Oscar's state-specific ACA and small-group plans — verify via the Oscar drug lookup tool or app. ACA/Individual (Oscar's core market): Mounjaro is covered for T2D with PA. Weight-loss GLP-1s, including Zepbound, are commonly excluded on ACA individual plans. Medicaid: Oscar has limited Medicaid presence; covered for T2D with PA where offered. The Lilly savings card ($25/month with coverage; $499/month without coverage, up to 13 fills, expires 12/31/2026) applies only to commercial plans — not Medicare or Medicaid.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month, up to 13 fills, expires 12/31/2026). Excludes government programs.
List price with no coverage — before any manufacturer savings card.
With coverage
Plan-specific commercial and ACA cost-share is not publicly published for Oscar. Verify on the Oscar drug lookup tool or app. With commercial coverage and the Lilly savings card: as little as $25/month.
Typical monthly copay once prior authorization is approved.
Bridge program
The 2026 Medicare GLP-1 Bridge ($50/month) covers weight-loss-approved products only; Mounjaro is not included.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Oscar's drug-level formulary and cost-share are not publicly confirmed — always verify on the Oscar drug lookup tool, the Oscar app, or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use the Oscar app or drug lookup to check your specific plan
Oscar is digital-first. Open the Oscar app or visit hioscar.com and use the drug search for your specific plan. Enter 'Mounjaro' or 'tirzepatide'. Because Oscar's formulary varies by state and plan, the national-level answer is 'covered for T2D with PA' — but your specific plan's tier and cost-share require checking directly in the app or on the website.
- 2
Have your prescriber prepare the prior authorization
Your prescriber needs to document your confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or higher, and prior metformin use or a documented contraindication. Your prescriber submits the PA on your behalf. Allow time for review — and confirm the PA criteria with Oscar member services before submission, as Oscar's drug-level PA details are not publicly published.
- 3
Contact Oscar member services for PA criteria and cost-share
Call the number on the back of your Oscar insurance card. Ask: Is Mounjaro covered for type 2 diabetes on my specific plan? What tier? What are the prior authorization requirements? What is my estimated copay? If you are asking about weight loss, the answer is no — Mounjaro is diabetes-only; the weight-loss tirzepatide is Zepbound, and it is commonly excluded on Oscar ACA plans.
Options if Oscar Health won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Often covered with prior authorization on Oscar commercial and ACA plans for T2D.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative; typically lower list price than Mounjaro and may be on a more favorable tier.
Jardiance (empagliflozin) or Farxiga (dapagliflozin)
SGLT2 inhibitors for T2D; often on preferred tiers and may be required as step therapy before GLP-1 approval on Oscar ACA plans.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management and obstructive sleep apnea. Covered separately from Mounjaro; commonly excluded on Oscar ACA individual plans. Verify on your specific Oscar plan's drug list. This is not a diabetes medication.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
No. Oscar Health does not cover Mounjaro for weight loss under any plan line. Mounjaro is FDA-approved for type 2 diabetes only; off-label weight-loss requests are denied. For weight loss, the same active ingredient (tirzepatide) is Zepbound — a separate FDA approval for chronic weight management. Zepbound is commonly excluded on Oscar ACA individual plans, where weight-loss GLP-1s are a standard exclusion. Verify on your specific Oscar plan's drug list.
Oscar does not publicly publish drug-level tier and copay details for its state-specific ACA and small-group plans at the national level. Unlike large PBM-owned carriers (Aetna/CVS Caremark, Cigna/Express Scripts) whose formularies are publicly searchable, Oscar's plan-specific cost-share varies by state and plan. Use the Oscar app, the Oscar website drug lookup for your specific enrolled plan, or call member services to confirm your out-of-pocket cost.
Oscar's Mounjaro PA criteria follow the standard pattern for ACA plans: confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or higher, and prior metformin step therapy or documented contraindication. Patient must be 18 or older; quantity limit is typically 4 pens per 28 days. However, Oscar's exact drug-level PA criteria are not publicly confirmed — verify directly with Oscar member services or through your prescriber's PA submission.
Oscar has limited Medicare Part D presence. Where Oscar Medicare Part D plans are available, Mounjaro is covered for type 2 diabetes only with prior authorization under standard Part D rules. The 2026 OOP cap is $2,100 and the Lilly savings card is not usable by Medicare beneficiaries. Mounjaro is not in the 2026 Medicare GLP-1 Bridge. Verify on your specific Oscar Medicare plan's formulary.
Yes, for Oscar commercial (employer-sponsored or ACA) plans only — not Medicare or Medicaid. The Lilly Mounjaro Savings Card offers as little as $25/month for commercially insured patients with Mounjaro coverage; $499/month (up to $647/month, 13 fills, expires 12/31/2026) without coverage. Not available to Medicare, Medicaid, or government-program beneficiaries.
Related Articles
Does Priority Health Cover Mounjaro? Michigan 2026 | Curex
Priority Health (MI) covers Mounjaro for T2D with prior auth — not weight loss. MI Medicaid's weight-loss GLP-1 coverage is for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Mounjaro? 2026 Guide | Curex
BCBS covers Mounjaro for type 2 diabetes with prior authorization — not for weight loss. The weight-loss tirzepatide is Zepbound, with separate coverage.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreDoes Blue Cross Blue Shield of Texas Cover Mounjaro? 2026 | Curex
BCBS of Texas covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The weight-loss tirzepatide is Zepbound, covered separately.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
You just saw how tangled Mounjaro coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Mounjaro. No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Oscar Health before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.